GlassScriptPhysician profile
Neil Patrick O Malley
NPI 1225055858
$2,469.77
in general payments reported to CMS, 2019-2025
21 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $959 · 2020: $199 · 2021: $325 · 2022: $338 · 2023: $339 · 2024: $206 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $425.86 | 2021-2024 | Intellis Adaptivestim, Crescent Spinal System, Adaptix Interbody System With Titan Nanolock Surface Technology |
| Globus Medical, INC. | $352.83 | 2019-2021 | |
| Medtronic USA, INC. | $341.25 | 2019-2020 | |
| Abbott Laboratories | $265.81 | 2020-2025 | Proclaim, Octrode, Eterna |
| Medacta USA, INC. | $164.70 | 2023-2025 | Nextar Spine Platform, Myspine |
| Si-Bone, INC. | $143.98 | 2022-2025 | |
| Boston Scientific Corporation | $122.17 | 2019-2020 | |
| Csl Behring | $109.57 | 2019-2020 | |
| Providence Medical Technology, INC. | $106.63 | 2021-2022 | |
| Stryker Corporation | $95.93 | 2019-2021 | |
| Xtant Medical INC | $76.64 | 2023 | |
| Ucb, INC. | $40.41 | 2019-2020 | |
| Saluda Medical Americas, INC. | $38.85 | 2024 | Evoke |
| Surgalign Spine Technologies, INC. | $37.17 | 2019 | |
| Acorda Therapeutics, INC | $35.03 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $23.83 | 2019 | |
| Ferring Pharmaceuticals INC. | $21.81 | 2019 | |
| Pacira Therapeutics, INC. | $21.26 | 2019 | |
| Upsher-Smith Laboratories LLC | $17.36 | 2020 | |
| Cerapedics INC. | $15.66 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Intrinsic Therapeutics | $13.02 | 2023 | Barricaid Acd (Annular Closure Device) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil O Malley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.